There will be a Rheumatology seminar scheduled for Wednesday, March 2 at 9:30am in the Degnan Conference Room of the Feinstein Institute for Medical Research. Our guest speaker will be Michael Carroll, PhD, professor of pediatrics and head of the Graduate program in Immunology at the Harvard Medical School. Dr. Carroll will be presenting “Is CNS lupus due to over active synaptic pruning by microglia?”
Target Audience: Fellows. Faculty and Community Adult Rheumatologists, Faculty Pediatric Rheumatologists, Medical Residents, Pediatric Residents, Adult Rheumatology trainees and Pediatric Rheumatology trainees, Nurses, Allied Health Professionals, PhD candidates, Post-Doctoral Fellows.
CME ACCREDITATION: Northwell Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATION: Northwell Health designates this live activity for a maximum of 1 AMA PRA Category 1 Credit. Each physician should only claim credit commensurate with the extent of their participation in the activity.
DISCLOSURE POLICY: Northwell Health adheres to the ACCME’s Standards for Commercial Support. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with commercial interests. All relevant conflicts of interest will be resolved prior to the commencement of the activity.
Planner and Speaker’s Disclosures: Michael Carroll, PHD, Diane Horowitz, MD, Anne Davidson, MD, Elena Katzap, DO, Julie Schwartzman, MD, and Galina Marder, MD have nothing to disclose. Richard Furie, MD receives research support from Anthera, Biogenidec, BMS, Celgene, Eli Lilly, Exagen, GlaxoSmithKline, Medimmune, NovaNordisk, Pfizer, Rigel and UCB for his role as a consultant and investigator; receives consulting fees from Amgen, Eisai, EMD Serono, Merck, Onyx, and Takeda; receives research support from Boehringer-Ingelheim, Dynavax, Genentech, Human Genome Sciences and NIAID for his role as investigator; research support from Novartis and Questcor Pharmaceuticals for his role as consultant.
Recognition of Program Support: An announcement of program support will be made to all attendees at the beginning of each Regularly Scheduled Session.
The post Rheumatology Series with Michael Carroll, PhD appeared first on The Feinstein Institute for Medical Research.
